| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12017-018-8497-7 |
| P698 | PubMed publication ID | 29846872 |
| P2093 | author name string | Gurcharan Kaur | |
| Muskan Gupta | |||
| P2860 | cites work | Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration | Q24614960 |
| Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases | Q24632768 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| Chaperone Hsp27, a novel subunit of AUF1 protein complexes, functions in AU-rich element-mediated mRNA decay | Q24658102 | ||
| Twenty years of research on cytokine-induced sickness behavior | Q24684760 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation | Q28182501 | ||
| c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis | Q28343409 | ||
| Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia | Q28508347 | ||
| Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
| The c-jun kinase/stress-activated pathway: regulation, function and role in human disease | Q30500831 | ||
| Neurotoxic reactive astrocytes are induced by activated microglia | Q33602850 | ||
| Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis | Q33748201 | ||
| Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. | Q33766743 | ||
| Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects | Q33855426 | ||
| Expression of chemokine genes in human dermal microvascular endothelial cell lines infected with Orientia tsutsugamushi | Q34006176 | ||
| Cytokine, sickness behavior, and depression. | Q34018621 | ||
| Biological basis of the behavior of sick animals | Q34048744 | ||
| Cytokine-induced sickness behaviour: mechanisms and implications | Q34114821 | ||
| Mechanisms and functions of p38 MAPK signalling. | Q34125736 | ||
| Natural anti-inflammatory agents for pain relief | Q34444693 | ||
| Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. | Q34588342 | ||
| Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss | Q34702307 | ||
| An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). | Q34729658 | ||
| Steroidal lactones from Withania somnifera, an ancient plant for novel medicine | Q34994211 | ||
| Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ) | Q35124699 | ||
| Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease | Q35212930 | ||
| Inflammation in central nervous system injury | Q35213716 | ||
| Sickness behavior as a new target for drug development | Q35899947 | ||
| Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. | Q35908588 | ||
| Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests | Q36054579 | ||
| Up-regulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation | Q36136789 | ||
| Withania somnifera leaf alleviates cognitive dysfunction by enhancing hippocampal plasticity in high fat diet induced obesity model | Q36295842 | ||
| MAPKAP kinases - MKs - two's company, three's a crowd | Q36371939 | ||
| Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide | Q36609461 | ||
| Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection. | Q36673413 | ||
| Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. | Q36693623 | ||
| Systemic immune activation leads to neuroinflammation and sickness behavior in mice | Q37044561 | ||
| Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease | Q37078772 | ||
| Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone | Q37148287 | ||
| Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study | Q37196355 | ||
| Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats | Q37224698 | ||
| Characterization of the sickness response in young and aging rats following E. coli infection | Q37437808 | ||
| The multifaceted profile of activated microglia. | Q37560782 | ||
| Torilin Inhibits Inflammation by Limiting TAK1-Mediated MAP Kinase and NF-κB Activation | Q37681561 | ||
| Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. | Q37763251 | ||
| The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. | Q37777395 | ||
| Microglial activation and chronic neurodegeneration | Q37794379 | ||
| An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda | Q38023388 | ||
| Inflammation in anxiety | Q38027750 | ||
| Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases | Q38236853 | ||
| Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells | Q38287673 | ||
| Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury | Q38470418 | ||
| Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases. | Q38522657 | ||
| Neurodegenerative diseases: From available treatments to prospective herbal therapy | Q38628617 | ||
| Infectious Agents and Neurodegenerative Diseases: Exploring the Links | Q39066147 | ||
| Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-κB signaling pathway in BV-2 microglia | Q39082239 | ||
| Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways | Q39093456 | ||
| Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia | Q39326276 | ||
| Luteolin inhibits microglial inflammation and improves neuron survival against inflammation | Q39532400 | ||
| Aqueous Leaf Extract of Withania somnifera as a Potential Neuroprotective Agent in Sleep-deprived Rats: a Mechanistic Study | Q39870272 | ||
| Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells | Q39932091 | ||
| Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study. | Q40446467 | ||
| Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. | Q40454128 | ||
| A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18. | Q42134649 | ||
| In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. | Q42164115 | ||
| Withania somnifera as a potential candidate to ameliorate high fat diet-induced anxiety and neuroinflammation | Q42376628 | ||
| Lipopolysaccharide-induced sickness behaviour evaluated in different models of anxiety and innate fear in rats. | Q42623948 | ||
| Modified Wu-Zi-Yan-Zong prescription, a traditional Chinese polyherbal formula, suppresses lipopolysaccharide-induced neuroinflammatory processes in rat astrocytes via NF-κB and JNK/p38 MAPK signaling pathways | Q42727033 | ||
| Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation | Q43119866 | ||
| Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. | Q44030464 | ||
| Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats | Q45748167 | ||
| Withania somnifera improves bone calcification in calcium-deficient ovariectomized rats. | Q46282084 | ||
| Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells | Q46544501 | ||
| Antiulcer and antioxidant activity of Asparagus racemosus Willd and Withania somnifera Dunal in rats | Q46875144 | ||
| Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally | Q46965442 | ||
| An aqueous extract of Withania somnifera root inhibits amyloid β fibril formation in vitro | Q47298268 | ||
| Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study | Q47639984 | ||
| Antistressor effect of Withania somnifera | Q47725939 | ||
| Withania somnifera as a potential anxiolytic and immunomodulatory agent in acute sleep deprived female Wistar rats | Q47781435 | ||
| SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes | Q47909610 | ||
| Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ. | Q49050188 | ||
| Withania somnifera Suppresses Tumor Growth of Intracranial Allograft of Glioma Cells. | Q50952029 | ||
| Cytokine and chemokine inter-regulation in the inflamed or injured CNS | Q57042010 | ||
| P38 Mitogen Activated Protein Kinase Regulates Endothelial VCAM-1 Expression at the Post-transcriptional Level | Q57243702 | ||
| Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes | Q73836168 | ||
| Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells | Q85968887 | ||
| Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats | Q86642284 | ||
| P433 | issue | 3 | |
| P921 | main subject | lipopolysaccharide | Q421804 |
| Withania somnifera | Q852660 | ||
| P304 | page(s) | 343-362 | |
| P577 | publication date | 2018-05-30 | |
| P1433 | published in | NeuroMolecular Medicine | Q15716731 |
| P1476 | title | Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation | |
| P478 | volume | 20 |
Search more.